Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,602 | 17,796 | 34,577 | 25,018 | N/A |
| Marketable Securities | N/A | N/A | 6,286 | 500 | N/A |
| Receivables | 8,690 | 4,706 | 1,900 | 1,765 | N/A |
| Inventories | 3,945 | 5,456 | 5,498 | 3,038 | N/A |
| TOTAL | $28,483 | $29,225 | $50,329 | $31,089 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1,930 | 2,777 | 3,378 | 4,068 | N/A |
| Investments And Advances | 1,340 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 400 | 352 | 1,069 | 1,336 | 0 |
| TOTAL | $3,670 | $3,129 | $4,447 | $5,404 | $N/A |
| Total Assets | $32,153 | $32,354 | $54,776 | $36,493 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,034 | 3,834 | 3,476 | N/A |
| Accounts payable and accrued liabilities | 2,224 | 2,860 | 2,725 | 1,188 | 0 |
| Accrued Expenses | 1,343 | 1,543 | 898 | 397 | N/A |
| Other current liabilities | 616 | 141 | 468 | 223 | N/A |
| TOTAL | $7,129 | $8,521 | $11,575 | $7,150 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,461 | 14,178 | 5,528 | 9,362 | N/A |
| Deferred Revenues | 758 | 1,412 | 2,652 | 1,010 | N/A |
| Other Non-Current Liabilities | 79 | 144 | 5,160 | 13,072 | 0 |
| TOTAL | $14,798 | $14,634 | $11,450 | $23,220 | $N/A |
| Total Liabilities | $21,927 | $23,155 | $23,025 | $30,370 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 2 | 10 | 10 | 9 | N/A |
| Retained earnings | -182,425 | -163,297 | -133,798 | -108,272 | N/A |
| Other shareholders' equity | 183,341 | 166,982 | 161,947 | 112,278 | 0 |
| TOTAL | $10,226 | $9,199 | $31,751 | $6,123 | $N/A |
| Total Liabilities And Equity | $32,153 | $32,354 | $54,776 | $36,493 | $0 |